Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors

Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors. Neuro-Oncology. 2006; 8:446-447.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.